| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 252 |
| 1 | INFLIXIMAB | 150 |
| 2 | RIBAVIRIN | 124 |
| 3 | METHOTREXATE SODIUM | 109 |
| 4 | PREDNISONE | 95 |
| 5 | METHOTREXATE | 90 |
| 6 | AZATHIOPRINE | 84 |
| 7 | ACETAMINOPHEN | 78 |
| 8 | METRONIDAZOLE | 66 |
| 9 | LEVOTHYROXINE SODIUM | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0556 |
| 1 | CIPROFLOXACIN AND DEXAMETHASONE | 1 | 0.0130 |
| 2 | HYDROCORTISONE 2.5% | 2 | 0.0124 |
| 3 | NELARABINE | 10 | 0.0103 |
| 4 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| 5 | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | 1 | 0.0068 |
| 6 | HETASTARCH | 1 | 0.0059 |
| 7 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| 8 | DESFLURANE | 9 | 0.0052 |
| 9 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 224 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 180 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 158 |
| 3 | Nucleoside Analog Antiviral [EPC] | 126 |
| 4 | Benzodiazepine [EPC] | 101 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 91 |
| 6 | Purine Antimetabolite [EPC] | 85 |
| 7 | Proton Pump Inhibitor [EPC] | 75 |
| 8 | Vitamin C [EPC] | 70 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 66 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 3 | Nucleoside Analog Antiviral [EPC] | 126 | 0.0015 |
| 4 | Anticholinergic [EPC] | 19 | 0.0012 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 66 | 0.0010 |
| 6 | beta Lactamase Inhibitor [EPC] | 4 | 0.0009 |
| 7 | Purine Antimetabolite [EPC] | 85 | 0.0009 |
| 8 | Bile Acid Sequestrant [EPC] | 10 | 0.0008 |
| 9 | Lipid Emulsion [EPC] | 2 | 0.0008 |